Today in News History
On July 12, several notable moments in the history of News stand out. In 1910, Charles Rolls, English engineer and businessman, co-founded Rolls-Royce Limited (born 1877) passed away. In 1967, Bruny Surin, Canadian sprinter was born. In 1967, Mac McCaughan, American singer and guitarist was born. In 1982, Jason Wright, American football player, businessman, and executive was born. In 1984, Sami Zayn, Canadian professional wrestler was born. In 1985, Ismael Londt, Surinamese-Dutch kickboxer was born. In 1985, Keven Lacombe, Canadian cyclist was born. In 1994, Eila Campbell, English geographer and cartographer (born 1915) passed away. In 2001, Space Shuttle program: Space Shuttle Atlantis is launched on mission STS-104, carrying the Quest Joint Airlock to the International Space Station. In 2013, Amar Bose, American businessman, founded the Bose Corporation (born 1929) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
INNOVATIONS: Enactus, NSE, NCDMB, others partner
By Ebunoluwa Sessou, Cynthia Alo Precious Enaike In a bid to accelerate the commercialisation of homegrown engineering solutions capable of addressing Nigeria’s development challenges, Enactus Nigeria, has established a partnership with several organizations and stakeholders to nurture young engineering talents to transform innovative ideas into practical solutions for national development through the Nigerian Engineering Olympiad [] The post INNOVATIONS: Enactus, NSE, NCDMB, others partner appeared first on Vanguard News.
Narrative Intelligence Brief
This article was published by Vanguard News, a source frequently categorized with a lean left bias based in Nigeria. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Vanguard News, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from Vanguard News
July 12, 2026
Rising costs of school graduations put parents under pressure
July 12, 2026
TikTokers Jarvis, Peller announce wedding date
July 12, 2026
SERAP sues INEC over ‘failure to probe alleged N800 billion FAAC diversion for campaign funding’
July 12, 2026
Marwa calls for girl-child protection, seeks traditional rulers’ support against drug abuse
July 12, 2026
Oriire pupils’ rescue: Collaboration key to tackling insecurity, says Gani Adams
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"cup semifinal"
Former Spanish PM Rajoy makes racist remarks about France's football team
[Photo] JUST IN: 🇦🇷 Argentina officially advances to the FIFA World Cup semifinal after defeat [...]
Argentina's hero: "We are just two steps away from the goal"
How other outlets are covering this story
Compare narratives across 5 related reports from 5 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
5 sources
Left 20%
Center 60%
Right 20%
The Eastern Herald
· Jul 8, 2026
Vertex’s $10 Billion Crinetics Takeover Signals Pharma’s Biggest Rare Disease Bet Yet
Vertex Pharmaceuticals is making its largest acquisition ever, placing a massive 10 billion bet on rare endocrine diseases with the purchase of Crinetics Pharmaceuticals. The deal marks a major strategic shift for the biotechnology leader, which has built its empire around cystic fibrosis treatments but is now expanding aggressively into new high-value therapeutic areas. Under the agreement, Vertex will acquire Crinetics for 85 per share in cash, representing an equity value of approximately 10 billion. The transaction is expected to close in the third quarter of 2026 after receiving customary regulatory approvals. The acquisition gives Vertex access to Crinetics’ growing
Investing.com
· Jun 30, 2026
Form 144 NEUROONE MEDICAL TECHNOLOGIES Corp For: 30 June
Form 144 NEUROONE MEDICAL TECHNOLOGIES Corp For: 30 June
The Motley Fool
· Jul 10, 2026
Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?
Additional blockbuster drugs may be on the horizon.
Seeking Alpha
· Jul 7, 2026
Vertex Pharmaceuticals Incorporated (VRTX) Crinetics Pharmaceuticals, Inc. - M&A Call - Slideshow
Vertex Pharmaceuticals Incorporated (VRTX) Crinetics Pharmaceuticals, Inc. - M&A Call - Slideshow
Economic Times
· Jun 22, 2026
Stocks to buy in 2026 for long term: BSE, Nykaa among 5 stocks that could give 10-20% return
We have collated a list of recommendations from top brokerage firms from ETNow and other sources.
Topics:
Related coverage for "INNOVATIONS: Enactus, NSE, NCDMB, others partner": The Eastern Herald — Vertex’s $10 Billion Crinetics Takeover Signals Pharma’s Biggest Rare Disease Bet Yet. Investing.com — Form 144 NEUROONE MEDICAL TECHNOLOGIES Corp For: 30 June. The Motley Fool — Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?. Seeking Alpha — Vertex Pharmaceuticals Incorporated (VRTX) Crinetics Pharmaceuticals, Inc. - M&A Call - Slideshow. Economic Times — Stocks to buy in 2026 for long term: BSE, Nykaa among 5 stocks that could give 10-20% return